News & Press Releases
Filter by:
Mintz Increases Global Recognition with New Chambers 2026 Rankings
February 24, 2026
Mintz continues to earn high rankings by Chambers Global, a guide to the top law firms and attorneys worldwide. Six Mintz attorneys and three of the firm’s practices are ranked in the 2026 Chambers Global edition.
Mintz Continues Strategic Growth of Its Patent Litigation Team with San Francisco Partner and Litigator for Life Sciences Innovators
February 24, 2026
Mintz is pleased to welcome Tung-On (T.O.) Kong, who has joined the firm as a Member in its Intellectual Property Division. A nationally recognized life sciences patent strategist, T.O. brings more than two decades of trial and appellate experience representing pharmaceutical, biotechnology, medical device, and diagnostics companies in bet-the-company disputes.
Five Mintz Attorneys Recognized as ‘Top Authors’ by JD Supra
February 24, 2026
Mintz is pleased to announce that five Attorneys have been named ‘Top Authors’ in their respective fields by JD Supra in its 2026 Readers’ Choice Awards. This annual award recognizes top authors and firms for their thought leadership in key topics and reaching high levels of visibility and engagement.
Press Release: Mintz Recognized in World Intellectual Property Review’s USA Patents Rankings 2025
February 24, 2026
World Intellectual Property Review (WIPR) USA Patents Ranking 2025 edition highlights the firms that handle the most consequential matters in the US and that have developed patent portfolios for some of the world’s biggest companies.
Mintz’s Sustainable Energy & Infrastructure Practice Achieves Record Year for High-Value Energy and Infrastructure Deals in 2025
February 12, 2026
Mintz’s Sustainable Energy & Infrastructure Practice advised on $5.6 billion in deals in 2025, closing over 60 transactions and marking over 200 completed transactions in the last three years. The team also commemorated 20 years since it was launched as the legal industry’s first integrated practice dedicated to the energy transition.
Mintz Advises Satellos Bioscience in Its US$57.2 Million Initial US Public Offering
February 10, 2026
Mintz advised Satellos Bioscience Inc. in its US$57.2 million public offering in the United States and Canada and the concurrent listing of its common shares on the Nasdaq Global Market under the trading symbol “MSLE”. Satellos’ common shares are also listed on the Toronto Stock Exchange under the trading symbol “MSCL”.
